Literature DB >> 12443872

Lactobacilli as live vaccine delivery vectors: progress and prospects.

Jos F M L Seegers1.   

Abstract

Evidence is accumulating that lactobacilli influence the immune response in a strain-dependent manner. This immunomodulatory capacity is important for the development of the immune response, and also identifies Lactobacillus as a potent oral vaccine carrier. Most of our current knowledge of the use of lactobacilli for vaccination purposes has been obtained with tetanus toxin fragment C (TTFC) as the model antigen. This knowledge, together with our ever-increasing understanding of the immune system and recent developments in cloning and expression techniques, should enable the utilisation of antigens other than TTFC and has made the development of lactobacilli as live vaccines a realistic prospect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443872     DOI: 10.1016/s0167-7799(02)02075-9

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  64 in total

1.  Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics.

Authors:  Piret Kõll; Reet Mändar; Imbi Smidt; Pirje Hütt; Kai Truusalu; Raik-Hiio Mikelsaar; Jelena Shchepetova; Kasper Krogh-Andersen; Harold Marcotte; Lennart Hammarström; Marika Mikelsaar
Journal:  Curr Microbiol       Date:  2010-05-05       Impact factor: 2.188

2.  Bacteriocin production by strain Lactobacillus delbrueckii ssp. bulgaricus BB18 during continuous prefermentation of yogurt starter culture and subsequent batch coagulation of milk.

Authors:  E D Simova; D M Beshkova; M P Angelov; Zh P Dimitrov
Journal:  J Ind Microbiol Biotechnol       Date:  2008-02-14       Impact factor: 3.346

Review 3.  Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research.

Authors:  Jens Walter
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

Review 4.  Actual concept of "probiotics": is it more functional to science or business?

Authors:  Michele Caselli; Francesca Cassol; Girolamo Calò; John Holton; Giovanni Zuliani; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 5.  Enhancing vaccine effectiveness with delivery technology.

Authors:  Marie Beitelshees; Yi Li; Blaine A Pfeifer
Journal:  Curr Opin Biotechnol       Date:  2016-03-06       Impact factor: 9.740

6.  Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines.

Authors:  Yakhya Dieye; Arjan J W Hoekman; Florence Clier; Vincent Juillard; Hein J Boot; Jean-Christophe Piard
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

Review 7.  The gastrointestinal microbiome: a malleable, third genome of mammals.

Authors:  Ian M Carroll; David W Threadgill; Deborah S Threadgill
Journal:  Mamm Genome       Date:  2009-07-21       Impact factor: 2.957

8.  Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

Authors:  Xinyuan Qiao; Guiwei Li; Xiangqing Wang; Xiaojing Li; Min Liu; Yijing Li
Journal:  BMC Microbiol       Date:  2009-12-04       Impact factor: 3.605

9.  Probiotics and gastrointestinal disease: successes, problems and future prospects.

Authors:  Eamonn P Culligan; Colin Hill; Roy D Sleator
Journal:  Gut Pathog       Date:  2009-11-23       Impact factor: 4.181

10.  Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.

Authors:  Vinay Saluja; Jean P Amorij; Maarten L van Roosmalen; Kees Leenhouts; Anke Huckriede; Wouter L J Hinrichs; Henderik W Frijlink
Journal:  AAPS J       Date:  2010-01-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.